Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies), By Animal Type (Companion Animals, Food Producing Animals), By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities), By Region and Competition, 2020-2030F

Market Overview

Global Veterinary Infectious Disease Diagnostics Market was valued at USD 1.52 Billion in 2024 and is expected to reach USD 2.04 Billion by 2030 with a CAGR of 5.25% during the forecast period.The global veterinary industry is experiencing a paradigm shift, with increased focus on preventive healthcare and diagnostics for animals. As concerns about zoonotic diseases and the economic impact of infectious outbreaks on livestock rise, the demand for advanced veterinary infectious disease diagnostics is growing. The Global Veterinary Infectious Disease Diagnostics Market is at the forefront of this evolution, playing a crucial role in safeguarding animal health, ensuring food safety, and preventing the transmission of diseases between animals and humans.

The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools. Advances in diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, have revolutionized the accuracy and speed of veterinary infectious disease diagnostics. These technologies allow for early detection and precise identification of pathogens. The growing trend of pet ownership has led to an increased demand for veterinary services, including diagnostics. Pet owners are increasingly investing in preventive healthcare for their animals, driving the demand for sophisticated diagnostic tests. With the globalization of the livestock industry, the risk of disease transmission across borders has escalated. This has prompted regulatory bodies and stakeholders to implement stringent diagnostic protocols to ensure the health and safety of animals and consumers.

Key Market Drivers

Increasing Pet Ownership and Humanization of Pets 

In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. According to the American Veterinary Medical Association (AVMA), the number of pet-owning households has significantly increased, with dog ownership growing at a faster pace rising from 31.3 million households in 1996 to 59.8 million in 2024. In comparison, cat-owning households have also seen growth, from 27 million to 42.1 million over the same period. This surge in pet ownership, coupled with the increasing humanization of pets, is driving the global veterinary infectious disease diagnostics market, as more pet owners seek advanced medical care for their animals. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.

This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.

The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.

Rising Incidence of Zoonotic Diseases 

Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market. Zoonotic diseases represent a significant public health concern, as evidenced by outbreaks such as the H1N1 influenza pandemic and the more recent COVID-19 pandemic. These diseases can originate in animals and jump to humans through various means, including direct contact, consumption of contaminated food or water, and exposure to vectors like mosquitoes and ticks. According to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are widespread both in the United States and globally. Research indicates that more than 60% of known infectious diseases in humans are transmitted from animals, and approximately 75% of new or emerging infectious diseases in humans originate from animals. This growing prevalence of zoonotic diseases is fueling the demand for advanced veterinary infectious disease diagnostics, driving market growth in this sector.

The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics. Efficient and accurate diagnostics play a pivotal role in preventing, controlling, and managing zoonotic diseases. In response to the rising threat, the global veterinary infectious disease diagnostics market has witnessed substantial growth. Diagnostic techniques include traditional methods such as serological testing and microbial culture, as well as advanced molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing.

Download Free Sample Report

Key Market Challenges

High Cost of Diagnostic Equipment

The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment. The high cost of diagnostic equipment limits access to advanced veterinary diagnostics, especially in developing regions. Rural areas, where agriculture is a significant part of the economy, often lack access to state-of-the-art diagnostic tools. This limited accessibility can impede early detection and timely intervention, allowing infectious diseases to spread unchecked.

Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market. High equipment costs can also hinder research and development efforts in veterinary diagnostics. Smaller companies and research institutions may find it challenging to invest in innovative technologies, slowing down progress in the field and limiting the development of new diagnostic methods. The cost of diagnostic services is inevitably passed on to pet owners and livestock farmers. This can deter individuals from seeking early diagnostic testing for their animals, leading to delayed disease detection and increased treatment costs in the long run.

Key Market Trends 

Technological Advancements

In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals. One of the primary drivers of the veterinary infectious disease diagnostics market is the continuous evolution of diagnostic technologies. Traditional methods are being replaced or complemented by more sophisticated and rapid techniques. Molecular diagnostics, next-generation sequencing, and advanced imaging technologies have become instrumental in providing quick and accurate diagnoses. These technologies not only enhance the speed of diagnosis but also improve the precision and reliability of results.

Segmental Insights

Technology Insights

Based on technology, Molecular Diagnostics emerged as the fastest growing segment in the global market for Veterinary Infectious Disease Diagnostics during the forecast period. Molecular diagnostic methods, including techniques like Polymerase Chain Reaction (PCR), enable the detection of pathogens at the genetic level, offering greater accuracy and sensitivity compared to traditional diagnostic approaches. This enhanced precision is essential for the early identification of infectious diseases, which leads to improved animal health outcomes. Furthermore, molecular diagnostics are highly effective in detecting emerging or novel pathogens that may be difficult to identify using conventional methods. This is particularly important in managing evolving infectious disease risks, including zoonotic diseases that can impact both animals and humans. Advancements in molecular technologies, such as miniaturization and automation, have also made these diagnostic tools more affordable and accessible to veterinary clinics and research institutions, driving their widespread adoption.

Animal Type Insights

Based on Animal Type, the companion animals emerged as the dominating segment in the global market for Veterinary Infectious Disease Diagnostics in 2024. As pets are increasingly regarded as family members, there is a stronger focus on providing them with premium care. Pet owners are more inclined to invest in veterinary services, including diagnostic tests, to ensure their pets’ health and well-being. This shift in mindset is driving the demand for advanced diagnostic technologies for companion animals. Additionally, the rising number of pet-owning households, particularly those with dogs and cats, is fueling the need for veterinary care. As the pet population grows, the demand for diagnostics to detect and manage infectious diseases also increases. Pet owners are becoming more proactive about their pets' health, seeking early diagnoses and preventive care to enhance their pets’ longevity and quality of life. This growing awareness has led to a greater reliance on diagnostics for early detection of infectious diseases, such as viral, bacterial, and parasitic infections. Furthermore, the expanding market for pet pharmaceuticals, vaccinations, and healthcare products further supports the need for diagnostic testing, with veterinary clinics and hospitals increasingly depending on these tools to guide treatment and improve care.

Download Free Sample Report

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Veterinary Infectious Disease Diagnostics Market in 2024. North America, particularly the United States, boasts one of the highest rates of pet ownership globally, with a substantial proportion of households owning dogs, cats, and other pets. As of 2024, 66% of U.S. households have a pet, equating to approximately 86.9 million families. This growing pet population drives the increased demand for veterinary services, including diagnostic testing. The rising trend of treating pets as family members in North America is leading to a greater emphasis on high-quality, advanced care, thus driving the need for sophisticated diagnostic tools to maintain pet health and well-being. According to the American Pet Products Association (APPA), U.S. pet-related expenditures reached 147 billion in 2023. North America also has well-established veterinary healthcare infrastructure with access to cutting-edge diagnostic technologies. Veterinary clinics and hospitals in the region are equipped with state-of-the-art tools for detecting infectious diseases in animals, reinforcing the region's dominance in the market. Furthermore, North American pet owners are more inclined to invest in veterinary services, including diagnostics, treatments, and preventive care, which has significantly contributed to the market's growth. The widespread availability of pet health information through veterinary organizations, pet health websites, and media outlets has heightened awareness of the importance of diagnostics for infectious diseases, leading to greater adoption of advanced diagnostic methods. These factors collectively create a favorable environment for the continued growth of the veterinary infectious disease diagnostics market, solidifying North America's leadership in the industry.

Recent Developments

• In November 2024, the European Medicine Agency's Committee for Veterinary Medicinal Products (CVMP) issued the first certificate for a vaccine platform technology master file (vPTMF), a move designed to facilitate and expedite the development and approval of new veterinary vaccines within the EU.
• In October 2024, the Department of Animal Husbandry and Dairying (DAHD), Government of India, introduced the "Standard Veterinary Treatment Guidelines (SVTGs)" for livestock and poultry. These guidelines were developed in partnership with the Food and Agriculture Organization (FAO) and supported by the United States Agency for International Development (USAID). They aim to assist veterinarians, animal health professionals, and paraprofessionals in providing standardized, evidence-based treatments for a range of animal diseases, thereby enhancing animal health and veterinary care across India. The SVTGs were created by a team of approximately 80 expert veterinarians with significant field experience.
• In October 2024, WOAH launched ZOOSURSY, a new disease surveillance initiative funded by the European Union.
• In January 2024, the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota launched a multi-country project aimed at preparing for the potential spillover of chronic wasting disease (CWD) from deer or other cervids to humans or non-cervid farm animals. The project is funded by the Minnesota Legislature, managed by the state Department of Natural Resources, and is led by CIDRAP along with CWD Project Director Michael Osterholm, PhD, MPH, and co-directors Jamie Umber, DVM, MPH, and Cory Anderson, PhD, MPH.

Key Market Players

• BIOMÉRIEUX
• Heska Corporation
• Neogen Corporation
• INDICAL BIOSCIENCE GmbH
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• DRG INSTRUMENTS GMBH
• Chembio Diagnostic Systems, Inc.
• Eurofins Technologies
• Agrolabo S.p.A.
• Abbott Laboratories inc.
• Danaher Corporation

Report Scope:

In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Infectious Disease Diagnostics Market, By Product:

o   Immunodiagnostics

o   Molecular Diagnostics

o   Other Veterinary Diagnostic Technologies

• Veterinary Infectious Disease Diagnostics Market, By Animal Type :

o   Companion Animals

o   Food Producing Animals

• Veterinary Infectious Disease Diagnostics Market, By End user:

o   Reference Laboratories

o   Veterinary Laboratories and Clinics

o   Point of Care / In House Testing

o   Research Institutes and Universities

• Veterinary Infectious Disease Diagnostics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Veterinary Infectious Disease Diagnostics Market.

Available Customizations:

Global Veterinary Infectious Disease Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Infectious Disease Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com